Skip to content
Screener

EPS (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.27-0.9%
Stryker logo
StrykerSYK
$3.30+44.1%
Globus Medical logo
Globus MedicalGMED
$1.10-26.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$0.22+37.1%
Enovis logo
EnovisENOV
-$0.02+96.9%
OrthoPediatrics logo
OrthoPediatricsKIDS
-$0.300.0%

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M

Valuation

See full
Market cap$418.73M-18.1%
Enterprise value$552.6M-11.4%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333822
(Unaudited, U.S. Dollars, in thousands, except per share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net loss$(15,798)$(14,081)$(36,706)$(67,175)
Net loss per common share:
Basic$(0.39)$(0.36)$(0.90)$(1.71)
Diluted(0.39)(0.36)(0.90)(1.71)
Weighted average number of common shares:
Basic40,90639,50140,67739,317
Diluted40,90639,50140,67739,317
Other comprehensive income (loss), before tax

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s EPS (diluted)?
Orthofix Medical Inc. (OFIX) reported EPS (diluted) of -$0.39 in Q2 2026.
How has Orthofix Medical Inc.'s EPS (diluted) changed year-over-year?
Orthofix Medical Inc.'s EPS (diluted) decreased by 8.3% year-over-year, from -$0.36 to -$0.39.
What is the long-term trend for Orthofix Medical Inc.'s EPS (diluted)?
Over 4 years (2021 to 2025), Orthofix Medical Inc.'s EPS (diluted) has grown at a 7.6% compound annual growth rate (CAGR), from -$1.74 to -$2.33.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Orthofix Medical Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude